-+ 0.00%
-+ 0.00%
-+ 0.00%

AN2 Therapeutics Participates in Three Upcoming Investor Conferences

PUBT·10/20/2026 20:14:03
Listen to the news
AN2 Therapeutics Participates in Three Upcoming Investor Conferences
  • AN2 Therapeutics will attend the Guggenheim 3rd Annual Healthcare Innovation Conference Nov. 9-11, 2026, with management available for one-on-one meetings.
  • CEO Eric Easom will participate in a fireside chat Nov. 9 at 9:30 a.m. ET.
  • Management will attend the Stifel 2026 Healthcare Conference Nov. 10-12, with one-on-one meetings available.
  • Easom will present a corporate overview Nov. 10 at 8:40 a.m. ET.
  • At the Jefferies London Conference, scheduled for Nov. 16-19, management will hold one-on-one meetings Nov. 17.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261020849168) on October 20, 2026, and is solely responsible for the information contained therein.